Novartis Venture Fund Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 9
Professionals
  • Investments
  • 309
  • Portfolio
  • 52
  • Exits
  • 141
Exits

Novartis Venture Fund General Information

Description

Founded in 1996, Novartis Venture Fund is a corporate venture capital arm of Novartis headquartered in Basel, Switzerland. The firm seeks to invest in the life sciences, oncology, biotechnology, and digital health sectors. The firm has an additional presence in Cambridge, Massachusetts.

Contact Information

Website
Year Founded
1996
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Growth/Expansion
Impact Investing
Venture Capital
Primary Office
  • Postfach
  • 4002 Basel
  • Switzerland
+41 061 000 00 00

Novartis Venture Fund Investments (309)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Exo Therapeutics 16-Dec-2020 Early Stage VC 0000 Drug Discovery Startup 00000 000000 00.0
0000 000000000 10-Dec-2020 00000 00000 0000 Other Healthcare Services Startup 00000 00000 00.0
0000000 10-Nov-2020 00000 00000 000.00 Drug Discovery Generating Revenue 0000 0000000
000000 00000000000 13-Oct-2020 00000 00000 000.00 Drug Discovery Product Development 0000 0000000
0000 (000000000000 21-Sep-2020 00000 00000 0000 Biotechnology Generating Revenue 000000 0000000000
000000 000 14-Sep-2020 00000 00000 0000 Biotechnology Clinical Trials - Phase 1
0000000 00 20-Aug-2020 00000 00000 0000 Other Healthcare Services Generating Revenue
0000000-000 18-Aug-2020 00000 00000 0000 Biotechnology Generating Revenue
GentiBio 05-Aug-2020 Seed Round 0000 Drug Discovery Startup 000000 0000000000
FoRx Therapeutics 22-Apr-2020 Seed Round 000.00 Drug Discovery Startup 0000000 00000000000000 00.0
You’re viewing 10 of 309 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novartis Venture Fund Exits (141)

Company Name Exit Date Exit Type Exit Size
Forma Therapeutics 11-Dec-2020 Public Investment 2nd Offering 00000
0000000000 0000000 07-Oct-2020 000000000 00000000 000.00
000000000 21-Sep-2020 000000000000000000 00000
0000000 0000000000 24-Jul-2020 000 00000
000000 26-Jun-2020 000 00000
00000 000000000000 19-Jun-2020 000 00000
0000000 0000000 00 15-Jun-2020 0000000000: 000000
0000000000 01-Apr-2020 000000000000000000
Microchips Biotech 20-Nov-2019 Merger/Acquisition
Galera Therapeutics 07-Nov-2019 IPO 0000
You’re viewing 10 of 141 exits. Get the full list »

Novartis Venture Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Novartis Venture Fund Team (27)

Name Title Deals Funds Boards Office
Anja König Ph.D Global Head 00 0 0 Basel, Switzerland
Bart Dzikowski Managing Director & Head of Transactions & Legal 0 Basel, Switzerland
Aaron Nelson Ph.D Managing Director 0 0 Cambridge, MA
Florian Muellershausen Ph.D Managing Director 0 0 Basel, Switzerland
Laura Brass Ph.D Managing Director 0 0 0 Cambridge, MA
You’re viewing 5 of 27 team members. Get the full list »

Novartis Venture Fund Co-Investors (195)

Name With Exits Lead Partner Series Industry
Johnson & Johnson Innovation - JJDC 6 0 Series chart Industry bar
AbbVie Ventures 0 0 Series chart Industry bar
Novo Holdings 0 00 Series chart Industry bar
OrbiMed 0 0 Series chart Industry bar
Life Sciences Partners 0 0 Series chart Industry bar
You’re viewing 5 of 195 co-investors. Get the full list »